Novartis To Make Its Medical Education Programs Virtual Under DOJ Settlement
Executive Summary
Two settlements totaling $729m resolve kickback claims related to speaker programs and copay charities; Novartis will limit payments to healthcare professionals for providing medical education under a new corporate integrity agreement.
You may also be interested in...
Alcohol, Repeat Attendees Could Raise Red Flags On Speaker Programs, OIG Attorney Says
Benjamin Wallfisch, a senior attorney at the Office of the Inspector General in the US Department of Health and Human Services, recently discussed how companies can avoid apparent violations of anti-kickback law while hosting educational programs.
COVID-19 Leads To Less Industry Spend On Docs, But Not Necessarily Less Influence
Drug and medical device company payments to doctors and hospitals for non-research related activities dropped for the first time in 2020 since CMS’s Open Payments database began collecting the information.
Pharma Companies Need To ‘Think A Little Bigger’ To Avoid Government Enforcement Actions
Industry executives note lessons learned from ‘fascinating’ approaches DOJ and states have taken in recent settlements, from restrictions on Novartis speaker programs to targeting McKinsey’s marketing advice. Chart includes details of 18 settlements since January 2020.